SB 145 makes several changes to Indiana pharmacy law, primarily expanding what pharmacists and certain pharmacy staff may do under standing orders, prescriptions, or protocols issued by the state health commissioner or a designated public health authority. It requires the commissioner to issue a standing order allowing pharmacists to treat, screen, test, administer, or dispense for specified conditions, including respiratory illnesses such as influenza, COVID-19, and RSV; strep throat; lice; minor skin conditions; and other emerging or existing public health threats. The bill also authorizes pharmacists to order certain waived laboratory tests, including CLIA-waived tests and FDA-cleared home-use tests, when used to guide clinical decision-making under a standing order.
The bill further expands the role of pharmacy interns and pharmacy technicians. Pharmacy interns may perform delegated CLIA-waived tests, and pharmacy technicians may perform delegated CLIA-waived tests and, if certified, may carry out additional delegated tasks that do not require a pharmacist’s clinical judgment and are not otherwise prohibited by rule or law. The bill also preserves and clarifies authority for pharmacists and pharmacy personnel to administer immunizations under existing legal frameworks, while requiring the pharmacy board to adopt rules on supervision, training, and competency for these activities.
SB 145 also adds a new civil and criminal immunity provision for pharmacists and pharmacies when filling prescriptions, including prescriptions that could be used to cause an abortion, unless the pharmacist has actual knowledge of that purpose. It states that the absence of a diagnosis or diagnosis code on a prescription does not itself create actual knowledge, and it limits immunity only where gross negligence, willful or wanton misconduct, fraud, or intentional acts are proven by clear and convincing evidence. A related provision adds a corresponding immunity section to Indiana’s civil liability chapter.
The overall sentiment reflected by the bill text is pro-expansion of pharmacy practice authority and public-health access, with an emphasis on improving access to testing, treatment, and immunizations through pharmacies. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of debate or support/opposition in the available materials. However, the inclusion of abortion-related prescription immunity suggests that the bill may have drawn or could draw controversy around reproductive health, pharmacist liability, and the scope of conscience or refusal-related protections.
Notable points of contention likely include the breadth of the commissioner’s authority to issue standing orders, the expansion of technician and intern duties, and the abortion-related immunity language. Supporters would likely view the bill as increasing access to care and reducing barriers in pharmacies, while critics may focus on patient safety, scope-of-practice concerns, and whether the immunity provisions could affect access to medications or accountability in dispensing decisions.
SB 145 would amend multiple sections of the Indiana Code governing public health and pharmacy practice, effective July 1, 2025. It expands the state health commissioner’s authority to authorize pharmacists and other licensed health professionals to administer or dispense immunizations and to allow pharmacists to treat or test for specified conditions under standing orders. It also creates new statutory authority for pharmacists to order certain CLIA-waived tests, broadens the delegated duties of pharmacy interns and certified pharmacy technicians, and adds civil and criminal immunity provisions related to prescription filling, including a new immunity section in Indiana’s civil liability chapter.
The bill appears generally favorable toward expanding pharmacy-based care and public access to treatment, testing, and immunization services. The text suggests a policy direction aimed at increasing convenience and responsiveness in community pharmacies. At the same time, the abortion-related immunity language and the expansion of non-pharmacist duties are the most likely sources of concern, particularly for those focused on reproductive health, patient safety, and professional scope-of-practice boundaries. No committee testimony or vote record was provided, so the available materials do not show a formal recorded level of support or opposition.
The main likely points of contention are the scope of authority given to the state health commissioner, the extent to which pharmacists can diagnose or treat conditions through standing orders, and the expanded role of pharmacy technicians and interns in testing and immunization. The bill’s immunity provisions for pharmacists filling prescriptions, especially the language tied to prescriptions that may be used to cause an abortion, are likely to be the most politically sensitive. Supporters would likely emphasize access and efficiency, while opponents may argue the bill weakens safeguards, blurs professional boundaries, or creates legal uncertainty around dispensing decisions.